Hamlet Pharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in Lund.

Quotes for Hamlet Pharma AB

Right Now

+/-
-0.03
%
-0,44%
Latest
6.8
High
7
Low
6.8
Volume
30 679
Turnover (SEK)
212 128
Value (MSEK)
739,6

Board

CEO

  • Mats Persson

Chairperson of the Board

  • Catharina Svanborg

Board

  • Bengt Westermark
  • Bill Hansson
  • Christer Köhler
  • Helena Lomberg
  • Rolf Carlsson

Videos

Largest Owners

Name Capital % Votes % Date
Catharina Svanborg 50,13 83,22 2021-09-30
Avanza Pension 4,57 1,16 2021-09-30
Nordnet Pensionsförsäkring 4,52 1,07 2021-09-30
Hans Nygren 1,81 0,43 2021-09-30
Rolf Karlsson 1,78 0,60 2021-09-30
Livförsäkringsbolaget Skandia 0,81 0,20 2021-09-30
Olle Jönsson 0,63 0,15 2021-09-30
Fredrik Herslow 0,60 0,23 2021-09-30
Swedbank Försäkring 0,55 0,13 2021-09-30
Handelsbanken Liv Försäkring AB 0,27 0,07 2021-09-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Upcoming reports

  • 2022-02-25 Delårsrapport 2022-Q2

  • 2022-05-20 Delårsrapport 2022-Q3

  • 2022-08-26 Bokslutskommuniké 2022

  • 2022-11-11 Delårsrapport 2023-Q1

  • 2022-11-24 Årsstämma 2022